Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades SEATTLE and VANCOUVER, British Columbia ...
Hoodline

From 'Fail Jail' To Future Medicine: Detroit Breaks Ground On Gratiot Life Sciences Hub

Construction starts at Detroit's 'fail jail' site — a new BAMF‑Henry Ford theranostics center leads the project.

Xtalks Named Media Partner for the Toronto Life Sciences and Biotech Summit

Xtalks is pleased to announce its role as an official Media Partner for the Toronto Life Sciences and Biotech Summit, taking ...

Achieve Life Sciences Announces Up to $354 Million Private Placement

Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio ...

Construction begins on life sciences building at site of fail jail

The two-story, 90,000-square-foot Gratiot Life Sciences Building is expected to be completed by the end of 2027, officials ...

Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients

Caris Life Sciences®, Inc. (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision ...

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 ...